Vitamin C plus rutin, in combination, shown to reduce oxidative stress markers in sciatic nerve. Vitamin C will be an aid in therapy to treat peripheral neuropathy.
both obesity and low testosterone are linked with promotion of inflammatory pathways [70–72] and exert harmful actions on the central [73–75] and peripheral [29,76] nervous systems
In general, obesity-related changes were worsened by low testosterone and improved by testosterone treatment; however, this relationship was not statistically significant in several instances. Further, our data suggest that a common pathway that may contribute to obesity and testosterone effects is regulation of inflammation
fasting blood glucose levels were independently and additively increased by GDX-induced testosterone depletion and high-fat diet
testosterone treatment significantly reduced fasting glucose under both the normal and high-fat diets, demonstrating potential therapeutic efficacy of testosterone supplementation
fasting insulin, insulin resistance (HOMA index), and glucose tolerance, low testosterone tended to exacerbate and or testosterone treatment improved outcomes.
testosterone status did not significantly affect body weight
testosterone’s effects likely do not indicate an indirect result on adiposity but rather regulatory action(s) on other aspects of metabolic homeostasis
Prior work in rodents has shown diet-induced obesity induces insulin resistance in rat brain [63] and that testosterone replacement improves insulin sensitivity in obese rats [64]. Our findings are consistent with the human literature, which indicates that (i) testosterone levels are inversely correlated to insulin resistance and T2D in healthy [30,65] as well as obese men [66], and (ii) androgen therapy can improve some metabolic measures in overweight men with low testosterone
it has been shown that TNFα has inhibitory effects on neuron survival, differentiation, and neurite outgrowth
Our data demonstrate that low testosterone and obesity independently increased cerebrocortical mRNA levels of both TNFα and IL-1β
Testosterone status also affected metabolic and neural measures
many beneficial effects of testosterone, including inhibition of proinflammatory cytokine expression
neuroprotection [80,81], are dependent upon androgen receptors, the observed effects of testosterone in this study may involve androgen receptor activation
testosterone can be converted by the enzyme aromatase into estradiol, which is also known to exert anti-inflammatory [82] and neuroprotective [83] actions
glia are the primary sources of proinflammatory molecules in the CNS
poorer survival of neurons grown on glia from mice maintained on high-fat diet
Since testosterone can affect glial function [86] and improve neuronal growth and survival [87–89], it was unexpected that testosterone status exhibited rather modest effects on neural health indices with the only significant response being an increase in survival in the testosterone-treated, high-fat diet group
significantly increased expression of TNFα and IL-1β in glia cultures derived from obese mice
testosterone treatment significantly lowered TNFα and IL-1β expression to near basal levels even in obese mice, indicating a protective benefit of testosterone across diet conditions
IL-1β treatment has been shown to induce synapse loss and inhibit differentiation of neurons
Testosterone status and diet-induced obesity were associated with significant regulation of macrophage infiltration
testosterone prevented and/or restored thermal nociception in both diet groups
a possible mechanism by which obesity and testosterone levels may affect the health of both CNS and PNS
Study points to obesity and low Testosterone contribution of neuroinflammation. No effect of body weight was seen with TRT. This animal model found similar positive effects of TRT in insulin sensitivity. Obesity and low T increase inflammatory cytokine production: this study found an increase in TNF-alpha and IL-1beta and TRT reduced TNF-alpha and IL-1beta to near base-line. Testosterone is neuroprotective and this study reviewed the small volume of evaded that pointed to benefit from estradiol. Testosterone's effect on glial survival was positive but not significant. Obesity and low T were found to be associated with increased macrophage infiltration in the PNS with increased TNF-alpha and IL-1beta. Testosterone therapy improved peripheral neuropathy via its positive effects on nocicieption.
Case report of 3 cases finds improvement in diabetic foot complications, including neuropathy, in men treated with Testosterone. This makes sense as the Testosterone will improve insulin function, improve HgbA1c and reduce inflammation in these men.
Only abstract available: chronic inorganic Hg associated with demyelinating sensorimotor polyneuropathy. The exposure in this case study was through herbal supplements.
A markedly increased risk of myopathy was observed
One cohort study (Women’s Health Initiative) of higher quality and larger sample size found stronger evidence of an increased risk of self-reported T2DM (OR=1.47; 95% CI 1.32 to 1.64) for the groups of women who reported statin use at baseline and three years later
Hippisley-Cox et al. found an increased risk of liver enzyme changes
weak evidence of an increased risk of type 2 diabetes mellitus (T2DM) was observed
Smeeth et al. found an increased risk of incident liver disease in the first year after the index date
The cumulative incidence of T2DM after three years of statin treatment was 6.25%, corresponding to an excess risk of 2.25%
We found no increased risk of peripheral neuropathy, depression, common eye diseases, renal disorders or arthritis associated with taking statins. Studies of higher quality did not show previously reported protective effects of statins on fractures, venous thrombo-embolism or pneumonia
There was evidence of an increase in myopathy, raised liver enzymes and diabetes.
Statin use associated with increased myopathy, liver dysfunction, and type II Diabetes. The authors conclude that the absolute risk is very low, yet OR was 1.47 for type II Diabetes (translated 47% increased odds of developing Diabetes as a result of statins) and OR of 2.63 in risk of myopathy (translated 163% increased odds of developing myopathy as a result of statins). Seems the authors "low risk" statement is just applies to those without symptoms/side effects. Physicians need to do a better job of understanding risks and customizing therapies.